TY - JOUR
T1 - Age-associated prevalence and risk factors of Lewy body pathology in a general population
T2 - The Hisayama study
AU - Wakisaka, Yoshinobu
AU - Furuta, Akiko
AU - Tanizaki, Yumihiro
AU - Kiyohara, Yutaka
AU - Iida, Mitsuo
AU - Iwaki, Toru
N1 - Funding Information:
Acknowledgements This study was supported by the Grant-in-Aid for Scientific Research (Grant-in-Aid for Exploratory research, no. 14657047) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We are grateful to Dr. Takeshi Iwatsubo (Department of Neuropathology and Neuroscience, University of Tokyo) for generously donating the α-synuclein antibody LB509. We are also grateful to Dr. Shibanosuke Katsuki and Dr. Masatoshi Fujishima, Emeritus Professors of Kyushu University, Dr. Teruo Omae, Emeritus President of the National Cardiovascular Disease Center of Japan, Dr. Yasuo Hi-rota, Dr. Moriyuki Takeshita, Dr. Kazuo Ueda, Dr. Yutaka Hasuo for their devotion to the Hisayama study.
PY - 2003/10/1
Y1 - 2003/10/1
N2 - In dementia with Lewy bodies (DLB), the Lewy bodies (LBs) are an essential substrate. Although LB pathology has gained increasing attention as one of the major causes of dementia, little is known about the exact prevalence of LB pathology in the general population. In addition, the pathology of Alzheimer-type dementia (ATD) is frequently associated with DLB. To investigate the prevalence of LB pathology in a community-based population and to evaluate the relationship between LB and ATD pathology, we performed an analysis of 102 consecutive autopsy cases. The survey extended over 2.5 years and autopsy rate was 70.5%. LB pathology was detected using α-synuclein immunohistochemistry and was assessed based on consensus guidelines for DLB. ATD pathology was evaluated by both CERAD and NIA-RI criteria. Twenty-nine subjects were clinically demented. LB pathology was present in 23 (22.5%) of 102 cases, and in 12 (41.4%) of the demented subjects. The LB score was not significantly different between DLB cases and non-demented subjects with LB pathology (nd-LB), while the Braak stages were significantly different between the two groups. Prevalence of LB pathology constantly increased with age. DLB cases accompanying severe ATD pathology showed more rapid increase of LB scores than did DLB cases without severe ATD pathology. Moreover, DLB cases with severe ATD pathology had poorer prognoses than those without severe ATD pathology. Our results suggested that aging and severe ATD pathology have a strong effect on the evolution of LB pathology.
AB - In dementia with Lewy bodies (DLB), the Lewy bodies (LBs) are an essential substrate. Although LB pathology has gained increasing attention as one of the major causes of dementia, little is known about the exact prevalence of LB pathology in the general population. In addition, the pathology of Alzheimer-type dementia (ATD) is frequently associated with DLB. To investigate the prevalence of LB pathology in a community-based population and to evaluate the relationship between LB and ATD pathology, we performed an analysis of 102 consecutive autopsy cases. The survey extended over 2.5 years and autopsy rate was 70.5%. LB pathology was detected using α-synuclein immunohistochemistry and was assessed based on consensus guidelines for DLB. ATD pathology was evaluated by both CERAD and NIA-RI criteria. Twenty-nine subjects were clinically demented. LB pathology was present in 23 (22.5%) of 102 cases, and in 12 (41.4%) of the demented subjects. The LB score was not significantly different between DLB cases and non-demented subjects with LB pathology (nd-LB), while the Braak stages were significantly different between the two groups. Prevalence of LB pathology constantly increased with age. DLB cases accompanying severe ATD pathology showed more rapid increase of LB scores than did DLB cases without severe ATD pathology. Moreover, DLB cases with severe ATD pathology had poorer prognoses than those without severe ATD pathology. Our results suggested that aging and severe ATD pathology have a strong effect on the evolution of LB pathology.
UR - http://www.scopus.com/inward/record.url?scp=0142030532&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0142030532&partnerID=8YFLogxK
U2 - 10.1007/s00401-003-0750-x
DO - 10.1007/s00401-003-0750-x
M3 - Article
C2 - 12904992
AN - SCOPUS:0142030532
SN - 0001-6322
VL - 106
SP - 374
EP - 382
JO - Acta neuropathologica
JF - Acta neuropathologica
IS - 4
ER -